The Anti-Influenza Virus Drug Rimantadine Has Trypanocidal Activity
Authors:
- 1 April 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (4) , 985-987
Abstract
We report here that bloodstream forms of the African trypanosome,Trypanosoma brucei, are sensitive to the anti-influenza virus drug rimantadine (50% inhibitory concentration of 1.26 μg ml−1 at pH 7.4). The activity is pH dependent and is consistent with a mechanism involving inhibition of the ability to regulate internal pH. Rimantadine is also toxic to the trypanosomatid parasites Trypanosoma cruzi and Leishmania major.Keywords
This publication has 19 references indexed in Scilit:
- Chemotherapy of leishmaniasis and trypanosomiasisCurrent Opinion in Infectious Diseases, 1997
- Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2Journal of Medicinal Chemistry, 1996
- Understanding the mechanism of action of the anti-influenza virus drug amantadineTrends in Microbiology, 1995
- Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi Genome ProjectMolecular and Biochemical Parasitology, 1995
- THE ROLE OF pH AND TEMPERATURE IN THE DEVELOPMENT OF LEISHMANIA PARASITESAnnual Review of Microbiology, 1994
- Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadineJournal of General Virology, 1994
- Influenza virus M2 protein has ion channel activityCell, 1992
- Rimantadine pharmacokinetics after single and multiple dosesAntimicrobial Agents and Chemotherapy, 1987
- Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homesAntimicrobial Agents and Chemotherapy, 1984
- Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adultsAntimicrobial Agents and Chemotherapy, 1981